Minerva Neurosciences (NERV) Misses Q2 EPS by 12c

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($1.09), $0.12 worse than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• U.S. and Denmark close in on a Greenland deal - Reuters
• Honeywell wins $53.9M Navy contract for navigation parts
• Axion Minerals plans flow-through private placement of up to $440K